Name: Peter Zonabend
Title: Chairman of the Board since May 2022, and member of the Board since March 2019. Chair of the Audit Committee and member of the Remuneration Committee.
Born: 1980
Education: LL.M from Stockholm University, EMLE from Université Paul Cézanne Aix-Marseille III, Bsc in Business and Economics from Stockholm University and DU EAED from Université Paul Cézanne Aix-Marseille III.
Holdings: 720,000 shares. Manages 79,917 shares by proxy.
Previous experience: CEO of Victoria Investments Holding Ltd, 2010-2017, Law Firm Fylgia, Law Firm Björn Rosengren. Board assignments within Hövding Sverige AB, HQ AB, TCER AB, CBD Solutions AB.
Other assignments: CEO Arwidsro, board assignment within Arwidsro and member of the Board of Hoist Finance AB.
Independent in relation to Vivesto and company management, not independent of major shareholders in the company.
Name: Hege Hellström
Title: Member of the Board since September 2019. Member of the Audit Committee.
Born: 1965
Education: B.Sc., Medical Laboratory Scientist, 1985, Oslo Metropolitan University, Norway
Holdings: -
Previous experience: Hege worked at the biotechnology company Sobi from 2013 until 2018 and was president for EMENAR (Europe, Middle East, North Africa and Russia). Prior to that, she was globally responsible for the Cardiovascular business area within Sanofi, VP Renal Europe and Head of Regional Liaisons at Sanofi, VP Renal and Endocrine Europe at Genzyme and General Manager Benelux at Genzyme. Before Genzyme, she was 13 years at Baxter.
Other assignments: Founder and manager of Belnor BVBA, a consultancy and investment company. She is also a non-executive Board member at Camurus AB (CAMX.ST), a Swedish biotech company, and Advicenne (Euronext: ADVIC), a French pharmaceutical company.
Independent in relation to Vivesto, the company management and to major shareholders of the company.
Name: Pål Ryfors
Title: Member of the Board since May 2022. Chair of the Remuneration Committee and member of the Audit Committee.
Born: 1983
Education: Bachelor in Financial Economics from Gothenburg School of Economics.
Holdings: -
Previous experience: Previously CFO for Episurf Medical, Marginalen Bank and Head of Group Controlling at Hoist Finance AB. Prior to that, he was an investment banker at Societe Generale in London, a position he assumed after holding several leading positions in the restructuring of the Swedish operations of Kaupthing Bank.
Other assignments: Chief Executive Officer of Episurf Medical AB and Chairman of the Board of Aros Kapital AB.
Independent in relation to Vivesto, the company management and to major shareholders of the company.
Name: Roger Tell
Title: Member of the Board since May 2022, and member of the Remuneration Committee.
Born: 1965
Education: Medical degree and a doctorate in experimental oncology from the Karolinska Institute in Sweden.
Holdings: -
Previous experience: Vice President of Clinical Development at Aprea Therapeutics and International Clinical Project Director at Servier in Suresnes, France. He has an extensive experience as an oncologist as well as an advisor to biopharma companies, including Eli Lilly, Astra Zeneca and Merck Serono.
Other assignments: Chief Scientific Officer and Chief Medical Officer of Isofol Medical AB
Independent in relation to Vivesto, the company management and to major shareholders of the company.
